Intelligence / Healthtech / De Novo Grants / Bridge TO Life, Ltd.
Approvalsnovel device granted (FDA De Novo)15 Jan 2026
Bridge TO Life, Ltd.
15 Jan 2026: Novel device granted (FDA De Novo) · VitaSmart Hypothermic Oxygenated Perfusion System. Recorded in the openFDA device 510(k) (De Novo decisions).
- Granted
- 15 Jan 2026
- Device
- VitaSmart Hypothermic Oxygenated Perfusion System
- Specialty
- Gastroenterology, Urology
- Product Code
- SGY
- Country
- United States
- Location
- Northbrook, IL
- Submitted
- 2025-03-31
- Reference
- DEN250009
What this signal means
A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.
- 2 added in the 30 days to 19 Nov 2026.
- Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS
Find the decision makers at Bridge TO Life, Ltd.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in Gastroenterology, Urology
De Novo Grants
20 AugCm Technologies, Inc.novel device granted (FDA De Novo) · Qoramatic Automated Stool ManagementApprovals30 AprCathbuddy, Inc.novel device granted (FDA De Novo) · Aurie SystemApprovals17 OctNeurovalens Limitednovel device granted (FDA De Novo) · Modius LeanApprovals
Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.